Septic shock in adults: guidelines of the All-Russian public organization “Federation of Anesthesiologists and Reanimatologists”

The paper represents the clinical guidelines for septic shock in adults, approved by the All-Russian public organization “Federation of anesthesiologists and reanimatologists” in 2023. Septic shock is a widespread condition with a high mortality rate. The recommendations cover the issues of etiology, pathogenesis, clinical signs and symptoms, methods of laboratory and instrumental diagnosis of septic shock. The clinical guidelines present initial therapy for septic shock, including approaches to vasopressor and inotropic therapy, recommendations for choosing antibacterial drugs, fluid and adjuvant therapy. The issues of surgical treatment of the infection are discussed. The article contains the criteria for the quality of medical care for the adult patients with septic shock and algorithms for the decision making in the diagnosis and intensive care of patients with septic shock.

[1]  Nathan Nielsen,et al.  Research priorities for therapeutic plasma exchange in critically ill patients , 2023, Intensive Care Medicine Experimental.

[2]  R. Bellomo,et al.  Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup , 2023, Nature Reviews Nephrology.

[3]  R. Bellomo,et al.  Hemoperfusion in the intensive care unit , 2022, Intensive Care Medicine.

[4]  S. Sakka,et al.  Extravascular lung water levels are associated with mortality: a systematic review and meta-analysis , 2022, Critical Care.

[5]  Daryl A Jones,et al.  Temporal changes in the epidemiology of sepsis‐related intensive care admissions from the emergency department in Australia and New Zealand , 2022, Emergency medicine Australasia : EMA.

[6]  Song-Tao Shou,et al.  Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis , 2022, BMC Infectious Diseases.

[7]  B. Erstad,et al.  Effect of fixed-dose hydrocortisone on vasopressor dose and mean arterial pressure in obese and nonobese patients with septic shock. , 2022, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[8]  Shota Yamamoto,et al.  ARDS Clinical Practice Guideline 2021 , 2022, Journal of Intensive Care.

[9]  A. Khanna,et al.  Timing of vasoactive agents and corticosteroid initiation in septic shock , 2022, Annals of Intensive Care.

[10]  S. Shlyapnikov,et al.  Application of Damage Control tactics in the treatment of patients with generalized peritonitis and septic shock , 2022, Grekov's Bulletin of Surgery.

[11]  Parisa Rashidi,et al.  Early Biomarker Signatures in Surgical Sepsis , 2022, The Journal of surgical research.

[12]  R. Ferrer,et al.  Fisiopatología del shock séptico , 2022, Medicina Intensiva.

[13]  Jin Zhang,et al.  Association of Blood Glucose Level and Glycemic Variability With Mortality in Sepsis Patients During ICU Hospitalization , 2022, Frontiers in Public Health.

[14]  J. Vincent,et al.  Septic shock: incidence, mortality and hospital readmission rates in French intensive care units from 2014 to 2018. , 2022, Anaesthesia, critical care & pain medicine.

[15]  Youping Deng,et al.  Association of Septic Shock with Mortality in Hospitalized COVID-19 Patients in Wuhan, China , 2022, Advances in virology.

[16]  Fang Wang,et al.  Continuous Renal Replacement Therapy With Adsorbing Filter oXiris in Acute Kidney Injury With Septic Shock: A Retrospective Observational Study , 2022, Frontiers in Medicine.

[17]  H. Fujieda,et al.  Comprehensive analysis of cytokine adsorption properties of polymethyl methacrylate (PMMA) membrane material , 2022, Journal of Artificial Organs.

[18]  C. Ronco,et al.  Clinical Assessment of Continuous Hemodialysis with the Medium Cutoff EMiC®2 Membrane in Patients with Septic Shock , 2022, Blood Purification.

[19]  V. Jha,et al.  Estimates of sepsis prevalence and outcomes in adult intensive care unit patients in India: a cross-sectional study. , 2022, Chest.

[20]  Sameer S. Kadri,et al.  Association Between Implementation of the Severe Sepsis and Septic Shock Early Management Bundle Performance Measure and Outcomes in Patients With Suspected Sepsis in US Hospitals , 2021, JAMA network open.

[21]  C. Sprung,et al.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 , 2021, Intensive Care Medicine.

[22]  T. Zewotir,et al.  Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients , 2021, BMC Infectious Diseases.

[23]  Tobias Hübner,et al.  First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock , 2021, Journal of clinical medicine.

[24]  X. Qiu,et al.  Multidimensional Evaluation of All-Cause Mortality Risk and Survival Analysis for Hospitalized Patients with COVID-19 , 2021, International journal of medical sciences.

[25]  B. Allaouchiche,et al.  Associations between peripheral perfusion disorders, mean arterial pressure and dose of norepinephrine administrated in the early phase of septic shock , 2021, Clinical and experimental pharmacology & physiology.

[26]  K. Fushimi,et al.  Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study , 2021, Annals of Intensive Care.

[27]  S. Gennai,et al.  Lack of admission biomarkers' clinical utility in outcomes prediction in patients suspected with infection in the emergency department. , 2021, The American journal of emergency medicine.

[28]  E. Ortiz-Prado,et al.  Prolonged Capillary Refilling as a Predictor of Mortality in Patients With Septic Shock , 2021, Journal of intensive care medicine.

[29]  K. Baharuddin,et al.  Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis , 2021, The western journal of emergency medicine.

[30]  V. Singhal,et al.  Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: A systematic review & meta-analysis. , 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  L. Camporota,et al.  Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study) , 2020, Critical Care.

[32]  S. di Saverio,et al.  Damage Control Surgery may be a Safe Option for Severe Non-Trauma Peritonitis Management: Proposal of a New Decision-Making Algorithm , 2020, World Journal of Surgery.

[33]  M. Singer,et al.  Effect of Extracorporeal Blood Purification on Mortality in Sepsis: A Meta-Analysis and Trial Sequential Analysis , 2020, Blood Purification.

[34]  B. Allaouchiche,et al.  Core-to-skin temperature gradient measured by thermography predicts day-8 mortality in septic shock: A prospective observational study. , 2020, Journal of critical care.

[35]  J. Bakker,et al.  A lactate-targeted resuscitation strategy may be associated with higher mortality in patients with septic shock and normal capillary refill time: a post hoc analysis of the ANDROMEDA-SHOCK study , 2020, Annals of Intensive Care.

[36]  L. Scott,et al.  The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience , 2020, Critical Care.

[37]  A. Dhala,et al.  Rapid Implementation and Innovative Applications of a Virtual Intensive Care Unit During the COVID-19 Pandemic: Case Study , 2020, Journal of medical Internet research.

[38]  Dong Zhang,et al.  Timing of norepinephrine initiation in patients with septic shock: a systematic review and meta-analysis , 2020, Critical Care.

[39]  B. Allegranzi,et al.  Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis , 2020, Intensive Care Medicine.

[40]  Dimitris Bertsimas,et al.  COVID-19 mortality risk assessment: An international multi-center study , 2020, medRxiv.

[41]  P. Schlattmann,et al.  Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis , 2020, Intensive Care Medicine.

[42]  C. Sohn,et al.  A mortality analysis of septic shock, vasoplegic shock and cryptic shock classified by the third international consensus definitions (Sepsis‐3) , 2020, The clinical respiratory journal.

[43]  F. Guirgis,et al.  Time to vasopressor initiation and organ failure progression in early septic shock , 2020, Journal of the American College of Emergency Physicians open.

[44]  R. Bellomo,et al.  Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference , 2020, Kidney international.

[45]  Fang Zhang,et al.  Prevalence of Antibiotic-Resistant Pathogens in Culture-Proven Sepsis and Outcomes Associated With Inadequate and Broad-Spectrum Empiric Antibiotic Use , 2020, JAMA network open.

[46]  Daryl A Jones,et al.  Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: A retrospective cohort study , 2020, Emergency medicine Australasia : EMA.

[47]  Y. Mehta,et al.  Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. , 2020, JAMA.

[48]  Shenmin Zhang,et al.  Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis , 2020, BMC Anesthesiology.

[49]  С. В. Сидоренко,et al.  МЕДОДИЧЕСКИЕ РЕКОМЕНДАЦИИ Российской некоммерческой общественной организации «Ассоциация анестезиологов-реаниматологов», Межрегиональной общественной организации «Альянс клинических химиотерапевтов и микробиологов», Межрегиональной ассоциации по клинической микробиологии и антимикробной химиотерапии , 2020 .

[50]  A. A. Solodov,et al.  Диагностика и интенсивная терапия острого респираторного дистресс-синдрома (Клинические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов») , 2020 .

[51]  J. D. Young,et al.  Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial. , 2020, JAMA.

[52]  Sanmarié Schlebusch,et al.  Antimicrobial-associated harm in critical care: a narrative review , 2020, Intensive Care Medicine.

[53]  O. Uzundere,et al.  Efficacy of HA330 Hemoperfusion Adsorbent in Patients Followed in the Intensive Care Unit for Septic Shock and Acute Kidney Injury and Treated with Continuous Venovenous Hemodiafiltration as Renal Replacement Therapy , 2020, Blood Purification.

[54]  Е. В. Фот,et al.  ЦЕЛЕНАПРАВЛЕННАЯ ДЕГИДРАТАЦИОННАЯ ТЕРАПИЯ ПРИ СЕПСИСЕ И ОСТРОМ РЕСПИРАТОРНОМ ДИСТРЕСС-СИНДРОМЕ ПОД КОНТРОЛЕМ ВОЛЮМЕТРИЧЕСКОГО МОНИТОРИНГА ГЕМОДИНАМИКИ , 2020 .

[55]  R. Bellomo,et al.  Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial. , 2020, JAMA.

[56]  M. Rech,et al.  Delayed vasopressor initiation is associated with increased mortality in patients with septic shock. , 2019, Journal of critical care.

[57]  A. Delaney,et al.  Safety of peripheral administration of vasopressor medications: A systematic review , 2019, Emergency medicine Australasia : EMA.

[58]  W. Schaffner,et al.  The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor - Active Surveillance in Selected Sites, United States, 2014-17. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[59]  W. Alhazzani,et al.  Predictors of gastrointestinal bleeding in adult ICU patients: a systematic review and meta-analysis , 2019, Intensive Care Medicine.

[60]  M. Soliman,et al.  Early Use of Norepinephrine Improves Survival in Septic Shock: Earlier than Early. , 2019, Archives of medical research.

[61]  J. Vincent,et al.  Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study , 2019, PloS one.

[62]  Ken Okamoto,et al.  Liberal versus restrictive red blood cell transfusion strategy in sepsis or septic shock: a systematic review and meta-analysis of randomized trials , 2019, Critical Care.

[63]  M. Nogueira,et al.  Excess mortality is associated with influenza A (H1N1) in patients with severe acute respiratory illness. , 2019, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[64]  K. Itani,et al.  Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events. , 2019, JAMA surgery.

[65]  T. Shin,et al.  Impact of timing to source control in patients with septic shock: A prospective multi-center observational study. , 2019, Journal of critical care.

[66]  J. Chiche,et al.  Formal guidelines: management of acute respiratory distress syndrome , 2019, Annals of Intensive Care.

[67]  S. Chevret,et al.  Mottling score is a strong predictor of 14-day mortality in septic patients whatever vasopressor doses and other tissue perfusion parameters , 2019, Critical Care.

[68]  Jeremy C. Weiss,et al.  Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. , 2019, JAMA.

[69]  Chao Qi,et al.  Rapid Detection of Methicillin‐Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial , 2019, Chest.

[70]  D. Eggink,et al.  Viral Factors Associated With the High Mortality Related to Human Infections With Clade 2.1 Influenza A/H5N1 Virus in Indonesia , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[71]  G. Martin,et al.  Crystalloids vs. colloids for fluid resuscitation in the Intensive Care Unit: A systematic review and meta‐analysis , 2019, Journal of critical care.

[72]  T. Rimmele,et al.  oXiris® Use in Septic Shock: Experience of Two French Centres , 2019, Blood Purification.

[73]  J. Bakker,et al.  Narrative review: clinical assessment of peripheral tissue perfusion in septic shock , 2019, Annals of Intensive Care.

[74]  Z. Molnár,et al.  Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study , 2019, Journal of critical care.

[75]  M. Kollef,et al.  Duration of Exposure to Antipseudomonal β‐Lactam Antibiotics in the Critically Ill and Development of New Resistance , 2019, Pharmacotherapy.

[76]  D. Wolk,et al.  Rapid Diagnostics for Blood Cultures: Supporting Decisions for Antimicrobial Therapy and Value-Based Care. , 2019, The journal of applied laboratory medicine.

[77]  M. Kollef,et al.  Outcomes Associated With De‐escalating Therapy for Methicillin‐Resistant Staphylococcus aureus in Culture‐Negative Nosocomial Pneumonia , 2019, Chest.

[78]  S. Bagshaw,et al.  Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial , 2018, Intensive Care Medicine.

[79]  M. A. Odena,et al.  Proteolysis in septic shock patients: plasma peptidomic patterns are associated with mortality , 2018, British journal of anaesthesia.

[80]  J. Marshall,et al.  Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial , 2018, JAMA.

[81]  M. Singer,et al.  Antibiotics for Sepsis-Finding the Equilibrium. , 2018, JAMA.

[82]  D. Wyncoll,et al.  Refractory septic shock: our pragmatic approach , 2018, Critical Care.

[83]  M. Nijsten,et al.  Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials , 2018, Critical Care.

[84]  M. Martín-Fernández,et al.  Shared Features of Endothelial Dysfunction between Sepsis and Its Preceding Risk Factors (Aging and Chronic Disease) , 2018, Journal of clinical medicine.

[85]  Manu L. N. G. Malbrain,et al.  Principles of fluid management and stewardship in septic shock: it is time to consider the four D’s and the four phases of fluid therapy , 2018, Annals of Intensive Care.

[86]  A. Delaney,et al.  Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis , 2018, Intensive Care Medicine.

[87]  M. Singer,et al.  Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study) , 2018, Intensive Care Medicine.

[88]  L. Epstein,et al.  Risk of Subsequent Sepsis Within 90 Days After a Hospital Stay by Type of Antibiotic Exposure , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[89]  T. Shin,et al.  Prognosis of patients excluded by the definition of septic shock based on their lactate levels after initial fluid resuscitation: a prospective multi-center observational study , 2018, Critical Care.

[90]  A. Dondorp,et al.  Haemodynamic assessment and support in sepsis and septic shock in resource-limited settings , 2017, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[91]  M. Amato,et al.  Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial , 2017, JAMA.

[92]  S. Hashemzadeh,et al.  Albumin As a Resuscitative Fluid in Patients with Severe Sepsis: A Randomized Clinical Trial , 2017 .

[93]  S. Cosgrove,et al.  Association of Adverse Events With Antibiotic Use in Hospitalized Patients , 2017, JAMA internal medicine.

[94]  N. Takeyama,et al.  Early evaluation of severity in patients with severe sepsis: a comparison with “septic shock” — subgroup analysis of the Japanese Association for Acute Medicine Sepsis Registry (JAAM‐SR) , 2017, Acute medicine & surgery.

[95]  T. van der Poll,et al.  Short-Course Adjunctive Gentamicin as Empirical Therapy in Patients With Severe Sepsis and Septic Shock: A Prospective Observational Cohort Study , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[96]  K. Soni,et al.  Levosimendan does not provide mortality benefit over dobutamine in adult patients with septic shock: A meta-analysis of randomized controlled trials. , 2017, Journal of clinical anesthesia.

[97]  G. Guyatt,et al.  A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension , 2017, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[98]  M. Levy,et al.  Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial , 2017, Intensive Care Medicine.

[99]  T. Lange,et al.  Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial , 2017, Intensive Care Medicine.

[100]  Alan E. Jones,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.

[101]  G. Angelini,et al.  The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta‐analysis of randomized trials , 2017, Journal of critical care.

[102]  S. Karanika,et al.  Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis. , 2016, International journal of antimicrobial agents.

[103]  C. Brun-Buisson,et al.  Septic shock with no diagnosis at 24 hours: a pragmatic multicenter prospective cohort study , 2016, Critical Care.

[104]  Arthur S Slutsky,et al.  Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study , 2018, Intensive care medicine.

[105]  B. Rochwerg,et al.  How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. , 2016, Journal of critical care.

[106]  J. Wernerman,et al.  Long-term outcomes in patients with septic shock transfused at a lower versus a higher haemoglobin threshold: the TRISS randomised, multicentre clinical trial , 2016, Intensive Care Medicine.

[107]  G. Perkins,et al.  Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. , 2016, JAMA.

[108]  Y. Mirzanejad,et al.  The impact of delayed biliary decompression and anti‐microbial therapy in 260 patients with cholangitis‐associated septic shock , 2016, Alimentary pharmacology & therapeutics.

[109]  Xiaoping Zhou,et al.  Prognostic value of extravascular lung water and its potential role in guiding fluid therapy in septic shock after initial resuscitation. , 2016, Journal of critical care.

[110]  J. Kellum,et al.  Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial. , 2016, JAMA.

[111]  M. Amato,et al.  Understanding recruitment maneuvers , 2016, Intensive Care Medicine.

[112]  S. Park,et al.  Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment , 2016, PloS one.

[113]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[114]  R. Bosman,et al.  The association between lactate, mean arterial pressure, central venous oxygen saturation and peripheral temperature and mortality in severe sepsis: a retrospective cohort analysis , 2016, Critical Care.

[115]  Christopher W Seymour,et al.  Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[116]  T. Rea,et al.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[117]  Sangeeta Mehta,et al.  Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial , 2016, Intensive Care Medicine.

[118]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[119]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[120]  Can Ince,et al.  Hemodynamic coherence and the rationale for monitoring the microcirculation , 2015, Critical Care.

[121]  T. van der Poll,et al.  Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study , 2015, Critical Care.

[122]  S. Koenig,et al.  Safety of peripheral intravenous administration of vasoactive medication. , 2015, Journal of hospital medicine.

[123]  H. Trappe,et al.  Earliest Bedside Assessment of Hemodynamic Parameters and Cardiac Biomarkers: Their Role as Predictors of Adverse Outcome in Patients with Septic Shock , 2015, International journal of medical sciences.

[124]  Leonard Leibovici,et al.  Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis , 2015, PloS one.

[125]  R. Green,et al.  A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. , 2015, Journal of critical care.

[126]  J. D. De Waele,et al.  Subtleties in practical application of prolonged infusion of β-lactam antibiotics. , 2015, International journal of antimicrobial agents.

[127]  G. Guyatt,et al.  Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis , 2015, Intensive Care Medicine.

[128]  G Greub,et al.  Blood culture-based diagnosis of bacteraemia: state of the art. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[129]  L. Harrison,et al.  Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008–2013: Results from Population-Based Surveillance , 2015, PloS one.

[130]  F. Guo,et al.  A high mean arterial pressure target is associated with improved microcirculation in septic shock patients with previous hypertension: a prospective open label study , 2015, Critical Care.

[131]  Pierre Asfar,et al.  Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature , 2015, Critical Care.

[132]  J. Navarro-Martínez,et al.  Comments on Cecconi et al.: Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine , 2015, Intensive Care Medicine.

[133]  D. Cook,et al.  The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis , 2014, Critical Care.

[134]  C. Ince,et al.  Dissociation between sublingual and gut microcirculation in the response to a fluid challenge in postoperative patients with abdominal sepsis , 2014, Annals of Intensive Care.

[135]  B. Zhao,et al.  Intensive Insulin Therapy for Septic Patients: A Meta-Analysis of Randomized Controlled Trials , 2014, BioMed research international.

[136]  Anand Kumar,et al.  Timing of vasopressor initiation and mortality in septic shock: a cohort study , 2014, Critical Care.

[137]  P. Böelle,et al.  Capillary refill time exploration during septic shock , 2014, Intensive Care Medicine.

[138]  K. Kinoshita,et al.  Time from admission to initiation of surgery for source control is a critical determinant of survival in patients with gastrointestinal perforation with associated septic shock , 2014, Critical Care.

[139]  J. Marshall,et al.  Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study , 2014, Critical Care.

[140]  J. Rodríguez-Baño,et al.  Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: impact on outcome of host, microorganism and therapy. , 2013, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[141]  L. Winston,et al.  Risk factors for methicillin-resistant Staphylococcus aureus in patients with community-onset and hospital-onset pneumonia. , 2013, Respiratory medicine.

[142]  M. Møller,et al.  Surgical delay is a critical determinant of survival in perforated peptic ulcer , 2013, The British journal of surgery.

[143]  Meng-Chih Lee,et al.  Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. , 2013, American journal of surgery.

[144]  M. Kollef,et al.  A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia , 2013, BMC Infectious Diseases.

[145]  J. Rodríguez-Baño,et al.  Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. , 2013, The Journal of antimicrobial chemotherapy.

[146]  J. Wetterslev,et al.  Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis , 2013, BMJ : British Medical Journal.

[147]  H. Borthwick,et al.  Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review , 2012, Annals of clinical biochemistry.

[148]  Joshua A. Doherty,et al.  Septic shock attributed to Candida infection: importance of empiric therapy and source control. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[149]  V. Kuzkov,et al.  Increased Extravascular Lung Water Reduces the Efficacy of Alveolar Recruitment Maneuver in Acute Respiratory Distress Syndrome , 2012, Critical care research and practice.

[150]  J. Sobel,et al.  Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[151]  J. Gonçalves-Pereira,et al.  Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams , 2011, Critical care.

[152]  P. Böelle,et al.  Mottling score predicts survival in septic shock , 2011, Intensive Care Medicine.

[153]  P. V. D. van der Voort,et al.  Mean glucose during ICU admission is related to mortality by a U-shaped curve in surgical and medical patients: a retrospective cohort study , 2010, Critical care.

[154]  Grace Y Chen,et al.  Sterile inflammation: sensing and reacting to damage , 2010, Nature Reviews Immunology.

[155]  L. Leibovici,et al.  Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. , 2010, The Journal of antimicrobial chemotherapy.

[156]  J. Horton,et al.  Etiology of illness in patients with severe sepsis admitted to the hospital from the emergency department. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[157]  A. Nathens,et al.  Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. , 2010, Surgical infections.

[158]  Johan Groeneveld,et al.  A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study , 2009, Intensive Care Medicine.

[159]  D. Marriott,et al.  Determinants of mortality in non-neutropenic ICU patients with candidaemia , 2009, Critical care.

[160]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[161]  C. Ince,et al.  Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study , 2009, Critical care.

[162]  E. Anaissie,et al.  Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[163]  Deborah J. Cook,et al.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.

[164]  Stephan M. Jakob,et al.  Arterial blood pressure during early sepsis and outcome , 2009, Intensive Care Medicine.

[165]  John A. Jones,et al.  Incidence of systemic fungal infection and related mortality following severe burns. , 2008, Burns : journal of the International Society for Burn Injuries.

[166]  Therapy Study Investigators,et al.  A comparison of epinephrine and norepinephrine in critically ill patients , 2008, Intensive Care Medicine.

[167]  J. Parrillo,et al.  Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis , 2008, Intensive Care Medicine.

[168]  D. Kontoyiannis,et al.  The changing epidemiology of invasive candidiasis , 2008, Cancer.

[169]  T. Calandra,et al.  Bench-to-bedside review: Candida infections in the intensive care unit , 2008, Critical care.

[170]  J. Paratz,et al.  Continuous infusion of β-lactam antibiotics in severe infections: a review of its role , 2007 .

[171]  K. Walley,et al.  Myocardial hypoxia-inducible HIF-1alpha, VEGF, and GLUT1 gene expression is associated with microvascular and ICAM-1 heterogeneity during endotoxemia. , 2007, American journal of physiology. Heart and circulatory physiology.

[172]  L. Cancio,et al.  Fungal Wound Infection (Not Colonization) Is Independently Associated With Mortality in Burn Patients , 2007, Annals of surgery.

[173]  P. Cabrales,et al.  Microvascular and capillary perfusion following glycocalyx degradation. , 2007, Journal of applied physiology.

[174]  J. Kellum,et al.  Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. , 2006, Chest.

[175]  B. Levy Lactate and shock state: the metabolic view , 2006, Current opinion in critical care.

[176]  K. Garey,et al.  Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[177]  V. Pettilä,et al.  Hemodynamic variables related to outcome in septic shock , 2005, Intensive Care Medicine.

[178]  J. Vincent,et al.  Red blood cell rheology in sepsis , 2003, Intensive Care Medicine.

[179]  M. Rybak,et al.  Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[180]  A. Sandilands,et al.  Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 β1‐adrenoceptors versus Gly389 β1‐adrenoceptors in isolated human atrial myocardium , 2003, British journal of pharmacology.

[181]  R. Busund,et al.  Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial , 2002, Intensive Care Medicine.

[182]  K. Giercksky,et al.  Significance of Candida recovered from intraoperative specimens in patients with intra-abdominal perforations. , 2002, Critical care medicine.

[183]  J. Kellum Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: Improved short-term survival and acid-base balance with Hextend compared with saline , 2002, Critical care medicine.

[184]  F B Taylor,et al.  Towards Definition, Clinical and Laboratory Criteria, and a Scoring System for Disseminated Intravascular Coagulation , 2001, Thrombosis and Haemostasis.

[185]  L. Saiman,et al.  Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[186]  E. Rackow,et al.  Effects of perfusion pressure on tissue perfusion in septic shock , 2000, Critical care medicine.

[187]  W. Sibbald,et al.  Endotoxin promotes adhesion of human erythrocytes to human vascular endothelial cells under conditions of flow , 2000, Critical care medicine.

[188]  M M Hirschl,et al.  Accuracy of oscillometric blood pressure measurement according to the relation between cuff size and upper‐arm circumference in critically ill patients , 2000, Critical care medicine.

[189]  W. Sessa,et al.  Vasomotor control in arterioles of the mouse cremaster muscle , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[190]  David M. Shade,et al.  Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. , 1999, Critical care medicine.

[191]  M. Bedel,et al.  The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. , 1999, Anesthesia and analgesia.

[192]  F Lemaire,et al.  Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. , 1998, American journal of respiratory and critical care medicine.

[193]  D. Pittet,et al.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. , 1995, JAMA.

[194]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.

[195]  M. V. Zakharov,et al.  Dynamics of endotoxin activity and cytokine concentration in patients with septic shock and acute kidney injury undergoing various methods of extracorporeal detoxification , 2022, Anesteziologiya i reanimatologiya.

[196]  OUP accepted manuscript , 2022, Clinical Kidney Journal.

[197]  Chung-Chi Huang,et al.  Outcomes of severe H1N1 pneumoniae: A retrospective study at intensive care units. , 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

[198]  J. Sciarretta,et al.  Rapid Source-Control Laparotomy: Is There a Mortality Benefit in Septic Shock? , 2018, Surgical infections.

[199]  T. van der Poll,et al.  Biomarkers in Sepsis. , 2018, Critical care clinics.

[200]  M. Kutuk,et al.  A single-center experience with resin adsorption hemoperfusion combined with continuous veno-venous hemofiltration for septic shock patients , 2018 .

[201]  Stein Silva,et al.  Hemodynamic Assessment of Patients With Septic Shock Using Transpulmonary Thermodilution and Critical Care Echocardiography: A Comparative Study , 2018, Chest.

[202]  J. Bakker,et al.  Circulatory shock: An update A tribute to Professor Max Harry Weil , 2012 .

[203]  Gabriele Neumann,et al.  H5N1 influenza viruses: outbreaks and biological properties , 2010, Cell Research.

[204]  Nancy Ballard,et al.  Patients' recollections of therapeutic paralysis in the intensive care unit. , 2006, American journal of critical care : an official publication, American Association of Critical-Care Nurses.